A new study found that women with type 1 diabetes had babies who were large for their gestational age, in spite of good diabetes management and glucose control during pregnancy, showing that even with excellent care, there are still challenges facing mothers with type 1 diabetes. Read more
The Omnipod Closed-Loop Insulin Delivery System is a hybrid closed-loop (HCL) system: it combines the technology of continuous glucose monitoring (CGM) and insulin pumps, and a personalized control algorithm to deliver insulin as needed, day and night. Research showed it helped patients stay in their target glucose range. Read more
Exercising with diabetes can be a challenge, and using some of the latest technologies can help you manage blood glucose and maximize exercise benefits. Blood glucose meters give immediate feedback on starting levels and single point-in-time exercise responses, while CGM devices offer the opportunity for better decision making in real-time and retrospectively, based on glucose […]
If you plan to travel by commercial airplane and have diabetes, it’s a good idea to prepare in advance for how to travel with the supplies you need. In the USA, the TSA allows diabetes-related supplies and medication through security checkpoints once they’ve been screened; they advise you to declare these items and separate them […]
New research showed that people with type 1 diabetes who used the Diabeloop DBLG1, a “closed-loop” insulin delivery system at home spent a larger percentage of time in their target glucose range, and experienced fewer hypoglycemic events, compared to patients who used an “open-loop” system — their regular pump and sensor. The Diabeloop DBLG1 system consists […]
New research suggests that adding an SGLT-2 inhibitor drug, dapagliflozin, to insulin therapy is helpful to patients with type 1 diabetes who are not able to maintain ideal blood glucose ranges with insulin alone. Because the drug can cause a slight increase in the kidney problem DKA, patients and their doctors should work closely together […]
New research suggests that women who work at their jobs for 45 or more hours a week have a higher risk of type 2 diabetes than women who work 35 to 40 hours each week. It’s not clear why working longer hours may increase diabetes risk in women, but the researchers suspect that doing more […]
A new mobile app from Medtronic called Sugar.IQ™, applies AI technology from IBM Watson Health to help people with diabetes make more informed decisions. In studies the app has shown that it can help people with diabetes in normal ranges more of the time. Read more
Researchers have been working on a way to deliver insulin in pill form instead of via injection for a long time, an innovation that would make the lives of people with type 1 diabetes much easier. However, they have struggled to find a method that would allow insulin to survive the human digestive system. Now […]
When combined, SGLT2 Inhibitor and GLP-1 RAs drugs show multiple benefits in treatment of type 2 diabetes. According to studies, the drug combination can target most of the issues that contribute to glucose intolerance, aiding in blood sugar control, weight management, blood pressure reduction, among others. Read more
A new study says that people who eat 1.5 tablespoons of walnuts per day have about half the diabetes risk of people who don’t eat walnuts. Eating about 3 tablespoons a day (about the recommended serving size for walnuts) reduced the risk to 47%. The researchers argue that this and the other health benefits documented […]
Exercising with type 1 diabetes can pose challenges, such as incidents of hypoglycemia. A new mini-dose glucagon has the potential to be a better option for treating exercise-induced hypoglycemia than other treatment methods, like eating carbohydrate-rich foods carbohydrate ingestion or reducing insulin dose. Read more
The “artificial pancreas” (an automated insulin delivery system) performed better in controlling blood sugar levels in hospitalized patients with type 2 diabetes compared than manual insulin delivery, a new study says. These devices have been used sucessfully to treat type 1 diabetes in non-hospitalized patients. The researchers believe their future use in hospital settings may […]
Dr. Scott Kahan, an expert in obesity and diabetes, discusses why our culture of blame surrounding obesity is harmful both physically and mentally, and how health care professionals can use compassionate dialogue to better help patients with diabetes manage their weight. Read more
A new study found that pregnant women who have any type of diabetes have increased risk that their child could develop autism. While the risk level varied depending on whether a woman had type 1, type 2, or gestational diabetes, all forms of diabetes showed some increase in risk. The researchers say this does not […]
Titanium dioxide is a common white pigment found in a range of ordinary items including paint and candy. Now a pilot study by researchers at The University of Texas at Austin has found crystalline particles of titanium dioxide in pancreas specimens with type 2 diabetes, suggesting that exposure to the white pigment is associated with […]
Sotagliflozin (brand name Zynquista), will be reviewed by the FDA as a possible adjunct treatment, along with insulin, for type 1 diabetes. If approved, it will be the first oral antidiabetes medication used in combination with insulin in patients diagnosed with type 1 diabetes. Read more
Bariatric surgeries such as gastric bypasses can have a dramatic impact on diabetes, even reversing the disease. However, it’s widely considered a treatment of last resort. Now many doctors and surgeons are starting to agree that surgery should be seen as a crucial aspect of diabetes care — perhaps even the best tool we have […]
Diabetes is a known risk factor for strokes. New research suggests that increased HbA1C levels are a key cause of first-time strokes, and researchers are now wondering if more stringent glycemic management at earlier stages may help in stroke prevention. Read more
Many recent clinical trials of new drugs for Alzheimer’s disease have ending in failure, and now some scientists are reconsidering whether we’ve been looking at the wrong things in our attempts to understand and treat the disease. Some researchers are now looking at the relationship between diabetes and Alzheimer’s, and how insulin may be the […]